medigraphic.com

2013, Number 1

<< Back Next >>

Rev Mex Med Repro 2013; 5.6 (1)

Trear or Not to Treat? The Effect of Medical Treatment on Couples with Idiopathic Recurrent Pregnancy Loss: What Do Scientific Evidence and Clinical Experience Say?

Luna RRM, Vela AG, Cervantes E, Vergara JAM, Batiza RVA, Colín NJJS

Language: Spanish
References: 38
Page: 9-17
PDF size: 250.45 Kb.


Text Extraction

No abstract


REFERENCES

  1. The Practice Committee of the American Society for Reproductive Medicine. Evaluation and treatment of recurrent pregnancy loss: a committee opinion. Fertil Steril 2012;98:1103-1111.

  2. Jacobs PA, Hassold T. Chromosome abnormalities: origin and etiology in abortion and livebirths. In: Vogel F, Sperling K, editors. Human Genetics. New York: Springer-Verlag, 1987.

  3. Stirrat GM. Recurrent miscarriage. Lancet 1990:336:673- 675.

  4. Quenby SM, Farquharson RG. Predicting recurrent miscarriage: what is important? Obstet Gynecol 1993;82:132-138.

  5. Tang A, Quenby S. Recent thoughts on management and prevention of recurrent early pregnancy loss. Curr Opin Obstet Gynecol 2010;22:446-451.

  6. Stephenson MD, Sierra S. Reproductive outcomes in recurrent pregnancy loss associated with a parental carrier of structural chromosome rearrangement. Hum Reprod 2006;21:1076-1082.

  7. Saravelos SH, Cocksedge KA, Li TC. Prevalence and diagnosis of congenital uterine anomalies in women with reproductive failure: a critical appraisal. Hum Reprod Update 2008;14:415-429.

  8. Greaves M, Cohen H, Machin SJ, Mackie I. Guidelines on the investigation and management of the antiphospholipod syndrome. Br J Haematol 2000;109;704-715.

  9. Rey E, Kahn SR, David M, Shrier I. Trombophilic disorders and fetal loss: a meta-analysis. Lancet 2003;361:901-908.

  10. Bansal AS. Joining the immunological dots in recurrent miscarriage. Am J Reprod Immunol 2010;64:307-315.

  11. Arredondo F, Noble LS. Endocrinology of recurrent pregnancy loss. Semin Reprod Med 2006;24:33-39.

  12. Christiansen OB, Nybo Andersen A, Bosch E, Daya S, et al. Evidence-based investigations and treatments of recurrent pregnancy loss. Fertil Steril 2005;83:821-839.

  13. Stray-Pedersen B, Stray-Pedersen S. Etiologic factors and subsequent reproductive performance in 195 couples with a prior history of habitual abortion. Am J Obstet Gynecol 1984;148:433-440.

  14. Brigham SA, Conlon C, Farquharson RG. A longitudinal study of pregnancy outcome following idiopathic recurrent miscarriage. Hum Reprod 1999;14:2868-2871.

  15. Lindbohm ML, Sallmen M, Taskinen H. Effects of exposure to environmental tobacco smoke on reproductive health. Scand J Work Environ Health 2002;28:84-86.

  16. Ness RB, Grisso JA, Hirshinger N, Markovic N, et al. Cocaine and tobacco use and the risk of spontaneous abortion. N Engl J Med 1999;340:333-339.

  17. Kesmodel U, Wisborg K, Olsen SF, Henriksen TB, Secher NJ. Moderate alcohol intake in pregnancy and the risk of spontaneous abortion. Alcohol 2002;37:435-444.

  18. Boots C, Stephenson MD. Does obesity increase the risk of miscarriage in spontaneous conception: a systemic review. Semin Reprod Med 2011;29:507-513.

  19. Royal Collage of Obstetricians and Gynaecologists. The investigation and treatment of couples with recurrent first trimester and second trimester miscarriage. 2011. http:// www.rcog.org.uk

  20. Kaandorp SP, Goddijn M, van der Post JA, et al. Aspirin plus heparin or aspirin alone in women with recurrent miscarriage. N Engl J Med 2010;362:1586-1596.

  21. Kaandrop S, di Nisio M, Goddijn M, Middeldrop S. Aspirin or anticoagulants for treating recurrent miscarriage in women without antiphospholipid syndrome. Cochrane Database Syst Rev 2009:CD 004734.

  22. Mantha S, Bauer KA, Zwicker JL. Low molecular weight heparin to achieve live birth following unexplained pregnancy loss: a systemic review. J Thromb Haemost 2010;8:263- 268.

  23. Clark P, Walker ID, Langhorne P, et al. SPIN (Scottish Pregnancy Intervention) Study: a multicenter, randomized controlled trial of low-molecular-weight-heparin and low dose aspirin in women with recurrent miscarriage. Blood 2010;115:4162-4167.

  24. Haas DM, Ramsey PS. Progestogen for preventive miscarriage. Cochrane Database Syst Rev 2008:CD003511.

  25. Porter TF, La Cursiere Y, Scott JR. Immunotherapy for recurrent miscarriage. Cochrane Database Syst Rev 2006:CD 000112.

  26. Carrell DT, Liu L, Peterson CM, Jones KP, et al. Sperm DNA fragmentation is increased in couples with unexplained recurrent pregnancy loss. Arch Androl 2003;49:49-55.

  27. Benchaib M, Lornage J, Mazoyer C, Lejeune H, et al. Sperm deoxyribonucleic acid fragmentation as a prognostic indicator of assisted reproductive technology outcome. Fertil Steril 2007;87:93-100.

  28. Fischer J, Colls P, Escudero T, Munne S. Preimplantation genetic diagnosis (PGD) improves pregnancy outcome for translocation carriers with a history of recurrent losses. Fertil Steril 2010;94:283-289.

  29. Bashiri A, Gete S, Mazor M, Gete M. Recurrent pregnancy loss-evaluation and treatment. Review. Harefuah 2011;151:852-856.

  30. Shapirta E, Ratzon R, Shoham-Vardi I, Serjienko R, et al. Primary vs secondary recurrent pregnancy loss –epidemiologic outcome. J Perinat Med. 2012;40:389-396.

  31. Bashiri A, Ratzon R, Amar S, Serjienko R, et al. Two vs three or more primary recurrent pregnancy losses-are there any differences in epidemiologic characteristics and index pregnancy outcome? J Perinat Med 2012;40:365-371.

  32. Stern JJ, Dorfmann AD, Gutierrez Najar AJ, Cerrillo M, Coulam CB. Frequency of abnormal karyotypes among abortuses from women with and without a history of recurrent spontaneous abortion. Fertil Steril 1996;65:250-253.

  33. Clark DA. The power of observation. Am J Reprod Immunol 2011;66:71-75.

  34. Coulam CB, Krysa L, Stern JJ, Bustillo M. Intravenous immunoglobulin for treatment of recurrent pregnancy loss. Am J Reprod Immunol 1995;34:333-337.

  35. Ticconi C, Giuliani E, Veglia M, Pietropolli A, et al. Thyroid autoimmunity and recurrent miscarriage. Am J Reprod Immunol 2011;66:452-459.

  36. Winger EE, Reed JL, Ashoush S, El-Toukhy T, et al. Preconception CD56+16+ adn/or Th1:Th2 levels predict benefit from IVIG therapy in subfertile women undergoing IVF. Am J Reprod Immunol 2011;66:394-403.

  37. Moraru M, Carbone J, Alecsandru D, Castillo-Rama M, Sanchez Ramon S. Intravenous immunoglobulin treatment increased live birth rate in a Spanish cohort of women with recurrent reproductive failure and expanded CD56+ cells. Am J Reprod Immunol 2012;68:75-84.

  38. Coulam CB, Stern JJ. Ultrasonographic findings of pregnancy loss after treatment for recurrent pregnancy loss: intravenous immunoglobulin versus placebo. Fertil Steril 1994;61:248-251.




2020     |     www.medigraphic.com